Ensifentrine, an inhaled PDE3/PDE4 inhibitor, in the treatment of chronic obstructive pulmonary disease.
chronic obstructive pulmonary disease (COPD)
Posted inAutoimmune Diseases, New Drugs, Regulatory
Tezspire: Effective Treatment for Severe Uncontrolled Asthma
Tezepelumab is a powerful new drug for asthma, invented by Amgen and AstraZeneca, with a completely new mechanism of action.